The FASEB Journal, Vol 9, 140-145, Copyright © 1995 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Beta PDGFR-IgG chimera demonstrates that human beta PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding

MA Heidaran, D Mahadevan and WJ Larochelle
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

To localize human beta PDGFR binding determinants, we constructed a fusion protein comprising beta PDGFR Ig-like domains 1 to 3 and an IgG1 Fc domain (beta PDGFR-HFc). beta PDGFR-HFc was expressed as a 200 kDa dimeric molecule and contained Fc epitopes as demonstrated by anti- mouse Fc antibody recognition. Scatchard analysis revealed that PDGF BB possessed a dissociation constant of 1.5 nM for beta PDGFR-HFc. Thus, beta PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding. We exploited this fusion protein technology to identify and characterize beta PDGFR antagonists using a sensitive beta PDGFR immunosorbent assay. In this assay, beta PDGFR-HFc half-maximally bound to PDGF BB with an affinity of around 150 pM. Suramin, as well as bacterially expressed and refolded human alpha PDGFR domains 1-3, inhibited beta PDGFR-HFc binding to PDGF BB half-maximally at 25 microM and 10 nM respectively. Therefore, alpha PDGFR D1-3, like beta PDGFR D1- 3, are sufficient for high affinity PDGF BB binding. Furthermore, the beta PDGFR-HFc immunosorbent assay will be useful to identify beta PDGFR antagonists as well as to study alpha and beta PDGFR substitution mutants which further map receptor binding determinants.

This article has been cited by other articles:

				K. Miyazawa, G. Backstrom, O. Leppanen, C. Persson, C. Wernstedt, U. Hellman, C.-H. Heldin, and A. Ostman Role of Immunoglobulin-like Domains 2-4 of the Platelet-derived Growth Factor alpha -Receptor in Ligand-Receptor Complex Assembly J. Biol. Chem., September 25, 1998; 273(39): 25495 - 25502. [Abstract] [Full Text] [PDF]

				N. A. Lokker, J. P. O'Hare, A. Barsoumian, J. E. Tomlinson, V. Ramakrishnan, L. J. Fretto, and N. A. Giese Functional Importance of Platelet-derived Growth Factor (PDGF) Receptor Extracellular Immunoglobulin-like Domains. IDENTIFICATION OF PDGF BINDING SITE AND NEUTRALIZING MONOCLONAL ANTIBODIES J. Biol. Chem., December 26, 1997; 272(52): 33037 - 33044. [Abstract] [Full Text] [PDF]

				T. Shulman, F. G. Sauer, R. M. Jackman, C. N. Chang, and N. F. Landolfi An Antibody Reactive with Domain 4 of the Platelet-derived Growth Factor beta  Receptor Allows BB Binding while Inhibiting Proliferation by Impairing Receptor Dimerization J. Biol. Chem., July 11, 1997; 272(28): 17400 - 17404. [Abstract] [Full Text] [PDF]

				D. Mahadevan, J.-C. Yu, J. W. Saldanha, N. Thanki, P. McPhie, A. Uren, W. J. LaRochelle, and M. A. Heidaran Structural Role of Extracellular Domain 1 of alpha-Platelet-derived Growth Factor (PDGF) Receptor for PDGF-AA and PDGF-BB Binding J. Biol. Chem., November 17, 1995; 270(46): 27595 - 27600. [Abstract] [Full Text] [PDF]

				S. Kumar, M. D. Minnich, and P. R. Young ST2/T1 Protein Functionally Binds to Two Secreted Proteins from Balb/c 3T3 and Human Umbilical Vein Endothelial Cells but Does Not Bind Interleukin 1 J. Biol. Chem., November 17, 1995; 270(46): 27905 - 27913. [Abstract] [Full Text] [PDF]